{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:25:48Z","timestamp":1792113948334,"version":"4.4.0"},"reference-count":184,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100009129","name":"Evidence Synthesis Programme","doi-asserted-by":"publisher","award":["NIHR131964"],"award-info":[{"award-number":["NIHR131964"]}],"id":[{"id":"10.13039\/501100009129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Ann Clin Transl Neurol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Spinal Muscular Atrophy (SMA) is a rare genetic disorder marked by progressive muscle weakness and mobility loss. It has a profound physical, emotional and social impact on patients and caregivers, requiring comprehensive medical and supportive care. SMA is classified into Types 1\u20134, with some individuals identified presymptomatically. This systematic review examined the safety and effectiveness of nusinersen and risdiplam for treating SMA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched research databases, relevant websites and existing systematic reviews. Screening, data extraction and quality assessment were conducted independently by two authors, with discrepancies resolved by a third. Internal quality appraisal ensured methodological rigour. A total of 131 studies reported in 148 sources were included. The review is registered with PROSPERO (CRD42024512226).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Both treatments showed improvements in motor function and milestones, with high survival rates across most SMA types. Motor function improvements were consistent, but other outcomes\u2014such as bulbar and respiratory function, and ventilation needs\u2014were variable. Adverse events were common across all treatments and SMA types, with some serious cases reported, including deaths in Types 1 and 2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>This comprehensive review highlights the clinical effectiveness and safety of nusinersen and risdiplam across all SMA types. However, variability in outcomes and limited comparative data introduce uncertainty. The findings underscore the need for more high\u2010quality randomised controlled trials to strengthen the evidence base for SMA treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/acn3.70274","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:26:44Z","timestamp":1764991604000},"page":"218-241","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness and Safety of Nusinersen and Risdiplam in Spinal Muscular Atrophy: A Systematic Review"],"prefix":"10.1002","volume":"13","author":[{"given":"Amin","family":"Mehrabian","sequence":"first","affiliation":[{"name":"Centre for Evidence and Implementation Science University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Auguste","sequence":"additional","affiliation":[{"name":"Centre for Evidence and Implementation Science University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Grove","sequence":"additional","affiliation":[{"name":"Centre for Evidence and Implementation Science University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4541-6232","authenticated-orcid":false,"given":"Anna","family":"Brown","sequence":"additional","affiliation":[{"name":"Centre for Evidence and Implementation Science University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette","family":"Parr","sequence":"additional","affiliation":[{"name":"Centre for Evidence and Implementation Science University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubarak","family":"Patel","sequence":"additional","affiliation":[{"name":"Centre for Evidence and Implementation Science University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furqan","family":"Butt","sequence":"additional","affiliation":[{"name":"Centre for Evidence and Implementation Science University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Donoghue","sequence":"additional","affiliation":[{"name":"Centre for Evidence and Implementation Science University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Yousefi","sequence":"additional","affiliation":[{"name":"Centre for Evidence and Implementation Science University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6542-8492","authenticated-orcid":false,"given":"Jo","family":"Parsons","sequence":"additional","affiliation":[{"name":"Centre for Evidence and Implementation Science University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"e_1_2_15_2_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.1062390"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2018.4"},{"key":"e_1_2_15_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41434\u2010022\u201000349\u2010y"},{"key":"e_1_2_15_5_1","volume-title":"GeneReviews [Internet]","author":"Prior T.","year":"2020"},{"key":"e_1_2_15_6_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.92731"},{"key":"e_1_2_15_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cuor.2006.09.006"},{"key":"e_1_2_15_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150640"},{"key":"e_1_2_15_9_1","unstructured":"P.Auguste J.Parsons M.Yousefi et\u00a0al. \u201cTreatment of Spinal Muscular Atrophy: Systematic Literature Review of Clinical and Cost\u2010Effectiveness Evidence(2024) https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42024512226."},{"key":"e_1_2_15_10_1","unstructured":"Spinal Muscular Atrophy UK \u201cSymptoms & Effects of 5q Spinal Muscular Atrophy: Type 3 \u201d 2024 https:\/\/smauk.org.uk\/support\u2010information\/about\u2010sma\/symptoms\u2010effects\u20105q\u2010sma\/symptoms\u2010type3\/."},{"key":"e_1_2_15_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijns10030056"},{"key":"e_1_2_15_12_1","unstructured":"National Institute for Health and Care Excellence (NICE) \u201cManaged Access Agreement: Nusinersen (SPINRAZA) for the Treatment of 5q Spinal Muscular Atrophy: NICE \u201d 2019 https:\/\/www.nice.org.uk\/guidance\/ta588\/resources\/managed\u2010access\u2010agreement\u2010july\u20102019\u2010pdf\u20106842812573."},{"key":"e_1_2_15_13_1","doi-asserted-by":"publisher","DOI":"10.5863\/1551\u20106776\u201024.3.194"},{"key":"e_1_2_15_14_1","volume-title":"FDA Approves First Drug for Spinal Muscular Atrophy","author":"U.S. Food & Drug Administration (FDA)","year":"2016"},{"key":"e_1_2_15_15_1","unstructured":"European Medicines Agency \u201cSpinraza: Nusinersen 2025 \u201d accessed March 10 2025 https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/spinraza."},{"issue":"8","key":"e_1_2_15_16_1","first-page":"1","article-title":"CADTH Reimbursement Recommendation: Nusinersen (Spinraza)","volume":"2","author":"CADTH","year":"2022","journal-title":"Canadian Journal of Health Technologies [Internet]"},{"key":"e_1_2_15_17_1","unstructured":"Australian Government. Department of Health. Therapeutic Goods Administration \u201cAustralian Public Assessment Report for Nusinersen (as Heptadecasodium) 2018 \u201d accessed March 10 2025 https:\/\/www.tga.gov.au\/sites\/default\/files\/auspar\u2010nusinersen\u2010heptadecasodium\u2010180813.pdf."},{"key":"e_1_2_15_18_1","volume-title":"Risdiplam for Treating Spinal Muscular Atrophy: Technology Appraisal Guidance TA755 [Internet]","author":"National Institute for Health and Care Excellence (NICE)","year":"2021"},{"key":"e_1_2_15_19_1","unstructured":"Spinal muscular Atrophy Australia Inc. SMA Milestone: Listing of Evrysdi for Children on the PBS(2021) https:\/\/smaaustralia.org.au\/sma\u2010milestone\u2010listing\u2010of\u2010risdiplam\u2010on\u2010the\u2010pbs\/."},{"key":"e_1_2_15_20_1","unstructured":"J.Stewart Evrysdi FDA Approval History: Drugs.com(2025) https:\/\/www.drugs.com\/history\/evrysdi.html."},{"key":"e_1_2_15_21_1","unstructured":"U.S. Food & Drug Administration (FDA) FDA Approves Oral Treatment for Spinal Muscular Atrophy(2020) https:\/\/www.fda.gov\/news\u2010events\/press\u2010announcements\/fda\u2010approves\u2010oral\u2010treatment\u2010spinal\u2010muscular\u2010atrophy."},{"key":"e_1_2_15_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1702752"},{"key":"e_1_2_15_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1710504"},{"key":"e_1_2_15_24_1","volume-title":"SmPC: Evrysdi 0.75 mg\/mL Powder for Oral Solution [Internet]","author":"Roche Products Limited","year":"2024"},{"key":"e_1_2_15_25_1","unstructured":"Spinal Muscular Atrophy UK \u201cRisdiplam: What It Is How It Works and Other FAQs [Internet] \u201d 2024 https:\/\/smauk.org.uk\/treatments\u2010research\/risdiplam\/risdiplam\u2010what\u2010how\u2010faqs\/."},{"key":"e_1_2_15_26_1","unstructured":"NHS \u201cSpinal Muscular Atrophy (SMA) \u201d 2020 https:\/\/www.nhs.uk\/conditions\/spinal\u2010muscular\u2010atrophy\u2010sma\/treatment\/."},{"key":"e_1_2_15_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.005"},{"key":"e_1_2_15_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.004"},{"key":"e_1_2_15_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2023.06.004"},{"key":"e_1_2_15_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1947216"},{"key":"e_1_2_15_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023\u2010021\u201002065\u2010z"},{"key":"e_1_2_15_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2022.04.006"},{"key":"e_1_2_15_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2866"},{"key":"e_1_2_15_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13101419"},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer\u20102021\u20100216"},{"key":"e_1_2_15_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006281.pub5"},{"key":"e_1_2_15_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006282.pub5"},{"key":"e_1_2_15_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325\u2010022\u201002089\u20102"},{"key":"e_1_2_15_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1152318"},{"key":"e_1_2_15_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325\u2010024\u201003101\u20107"},{"key":"e_1_2_15_41_1","volume-title":"Nusinersen and Risdiplam for Treating Spinal Muscular Atrophy (Review of TA588 and TA755) [ID6195]","author":"National Institute for Health and Care Excellence (NICE)","year":"2025"},{"key":"e_1_2_15_42_1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. [Internet]","author":"Higgins J.","year":"2024"},{"key":"e_1_2_15_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_15_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4898"},{"key":"e_1_2_15_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919"},{"key":"e_1_2_15_46_1","volume-title":"Systematic Reviews of Etiology and Risk","author":"Moola S.","year":"2020"},{"key":"e_1_2_15_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27853"},{"key":"e_1_2_15_48_1","unstructured":"European Medicines Agency Assessment Report: Evrysdi. Procedure No. EMEA\/H\/C\/005145\/II\/0005\/G [Internet](2023) https:\/\/www.ema.europa.eu\/en\/documents\/variation\u2010report\/evrysdi\u2010h\u2010c\u2010005145\u2010ii\u20100005\u2010g\u2010epar\u2010assessment\u2010report\u2010variation_en.pdf."},{"key":"e_1_2_15_49_1","unstructured":"European Medicines Agency Assessment Report: Spinraza. Procedure No. EMEA\/H\/C\/004312\/0000 [Internet](2017) https:\/\/www.ema.europa.eu\/en\/documents\/assessment\u2010report\/spinraza\u2010epar\u2010public\u2010assessment\u2010report_en.pdf\u20100."},{"key":"e_1_2_15_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild\u20102022\u2010323899"},{"key":"e_1_2_15_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.01.008"},{"key":"e_1_2_15_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325\u2010024\u201002845\u20106"},{"key":"e_1_2_15_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474\u20104422(22)00339\u20108"},{"key":"e_1_2_15_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431\u2010024\u201005735\u20109"},{"key":"e_1_2_15_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41372\u2010021\u201001301\u20105"},{"key":"e_1_2_15_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25795"},{"key":"e_1_2_15_57_1","doi-asserted-by":"publisher","DOI":"10.3233\/JND\u2010200533"},{"key":"e_1_2_15_58_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10235540"},{"key":"e_1_2_15_59_1","doi-asserted-by":"publisher","DOI":"10.5603\/PJNNS.a2021.0020"},{"key":"e_1_2_15_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25533"},{"key":"e_1_2_15_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51276"},{"key":"e_1_2_15_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15768"},{"key":"e_1_2_15_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1474\u20104422(21)00251\u20109"},{"key":"e_1_2_15_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1474\u20104422(21)00001\u20106"},{"key":"e_1_2_15_65_1","doi-asserted-by":"publisher","DOI":"10.3233\/JND\u2010190465"},{"key":"e_1_2_15_66_1","doi-asserted-by":"publisher","DOI":"10.1177\/18632521241235028"},{"key":"e_1_2_15_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2024.05.003"},{"key":"e_1_2_15_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.03.012"},{"key":"e_1_2_15_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120\u2010023\u201000444\u20101"},{"key":"e_1_2_15_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.28225"},{"key":"e_1_2_15_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51411"},{"key":"e_1_2_15_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15005"},{"key":"e_1_2_15_73_1","volume-title":"Nusinersen for Treating Spinal Muscular Atrophy TA588. Managed Access Agreement Treatment Criteria Evidence Review: Non\u2010Ambulant Type III Spinal Muscular Atrophy Population: Company Evidence Submission","author":"Biogen","year":"2020"},{"key":"e_1_2_15_74_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023\u2010020\u201001414\u20108"},{"key":"e_1_2_15_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2023.10.009"},{"key":"e_1_2_15_76_1","doi-asserted-by":"publisher","DOI":"10.3233\/JND\u2010230162"},{"key":"e_1_2_15_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27187"},{"key":"e_1_2_15_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25142"},{"key":"e_1_2_15_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023\u2010022\u201002420\u20108"},{"key":"e_1_2_15_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51560"},{"key":"e_1_2_15_81_1","doi-asserted-by":"publisher","DOI":"10.3390\/children9121829"},{"key":"e_1_2_15_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072\u2010023\u201006698\u20109"},{"key":"e_1_2_15_83_1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11091244"},{"key":"e_1_2_15_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415\u2010024\u201012203\u20109"},{"key":"e_1_2_15_85_1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000002445"},{"key":"e_1_2_15_86_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007527"},{"key":"e_1_2_15_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2022.04.003"},{"key":"e_1_2_15_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51340"},{"key":"e_1_2_15_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27938"},{"key":"e_1_2_15_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/apa.16974"},{"key":"e_1_2_15_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27950"},{"key":"e_1_2_15_92_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S449066"},{"key":"e_1_2_15_93_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp\u20102020\u2010323822"},{"key":"e_1_2_15_94_1","doi-asserted-by":"publisher","DOI":"10.3233\/jnd\u2010200551"},{"key":"e_1_2_15_95_1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000009914"},{"key":"e_1_2_15_96_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756286421998902"},{"key":"e_1_2_15_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51514"},{"key":"e_1_2_15_98_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023\u2010022\u201002547\u20108"},{"key":"e_1_2_15_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2024.01.005"},{"key":"e_1_2_15_100_1","doi-asserted-by":"publisher","DOI":"10.3233\/JND\u2010230197"},{"key":"e_1_2_15_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474\u20104422(21)00367\u20107"},{"key":"e_1_2_15_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00455\u2010023\u201010584\u2010z"},{"key":"e_1_2_15_103_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883\u2010023\u201003261\u2010z"},{"key":"e_1_2_15_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2024.01.001"},{"key":"e_1_2_15_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15499"},{"key":"e_1_2_15_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415\u2010023\u201011560\u20101"},{"key":"e_1_2_15_107_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12081782"},{"key":"e_1_2_15_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.28311"},{"key":"e_1_2_15_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2024.12.001"},{"key":"e_1_2_15_110_1","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200298"},{"key":"e_1_2_15_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2024.05.011"},{"key":"e_1_2_15_112_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S305849"},{"key":"e_1_2_15_113_1","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint16030047"},{"key":"e_1_2_15_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2021.10.011"},{"key":"e_1_2_15_115_1","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14412"},{"key":"e_1_2_15_116_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno\u20102021\u2010000164"},{"key":"e_1_2_15_117_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102074"},{"key":"e_1_2_15_118_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12082839"},{"key":"e_1_2_15_119_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415\u2010023\u201011711\u20104"},{"key":"e_1_2_15_120_1","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint16050067"},{"key":"e_1_2_15_121_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl\u20102020\u2010216564"},{"key":"e_1_2_15_122_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1391613"},{"key":"e_1_2_15_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415\u2010024\u201012318\u2010z"},{"key":"e_1_2_15_124_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1294028"},{"key":"e_1_2_15_125_1","doi-asserted-by":"publisher","DOI":"10.3233\/JND\u2010240017"},{"key":"e_1_2_15_126_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415\u2010020\u201010223\u20109"},{"key":"e_1_2_15_127_1","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2022.01094"},{"key":"e_1_2_15_128_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12154901"},{"key":"e_1_2_15_129_1","doi-asserted-by":"publisher","DOI":"10.1212\/cpj.0000000000001033"},{"key":"e_1_2_15_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20104642(21)00100\u20100"},{"key":"e_1_2_15_131_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023\u2010021\u201001961\u20108"},{"key":"e_1_2_15_132_1","doi-asserted-by":"publisher","DOI":"10.1055\/a\u20102379\u20107069"},{"key":"e_1_2_15_133_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27217"},{"key":"e_1_2_15_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2023.04.007"},{"key":"e_1_2_15_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100862"},{"key":"e_1_2_15_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474\u20104422(20)30037\u20105"},{"key":"e_1_2_15_137_1","doi-asserted-by":"publisher","DOI":"10.3233\/JND\u2010230077"},{"key":"e_1_2_15_138_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010024\u201067627\u20100"},{"key":"e_1_2_15_139_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325\u2010024\u201002852\u20107"},{"key":"e_1_2_15_140_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp\u20102020\u2010324254"},{"key":"e_1_2_15_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2020.12.006"},{"key":"e_1_2_15_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2022.06.001"},{"key":"e_1_2_15_143_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11101515"},{"key":"e_1_2_15_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2023.06.008"},{"key":"e_1_2_15_145_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200986"},{"key":"e_1_2_15_146_1","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint16060096"},{"key":"e_1_2_15_147_1","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3630"},{"key":"e_1_2_15_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2024.06.005"},{"key":"e_1_2_15_149_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123418"},{"key":"e_1_2_15_150_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023\u2010023\u201002769\u20104"},{"key":"e_1_2_15_151_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14902"},{"key":"e_1_2_15_152_1","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2706179"},{"key":"e_1_2_15_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2020.05.004"},{"key":"e_1_2_15_154_1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11030367"},{"key":"e_1_2_15_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2020.11.004"},{"key":"e_1_2_15_156_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac252"},{"key":"e_1_2_15_157_1","doi-asserted-by":"publisher","DOI":"10.3233\/JND\u2010221600"},{"key":"e_1_2_15_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2024.104316"},{"key":"e_1_2_15_159_1","doi-asserted-by":"publisher","DOI":"10.3390\/children11080886"},{"key":"e_1_2_15_160_1","doi-asserted-by":"publisher","DOI":"10.3233\/JND\u2010210735"},{"key":"e_1_2_15_161_1","doi-asserted-by":"publisher","DOI":"10.1055\/s\u20100042\u20101750719"},{"key":"e_1_2_15_162_1","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac269"},{"key":"e_1_2_15_163_1","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14051"},{"key":"e_1_2_15_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2020.05.002"},{"key":"e_1_2_15_165_1","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2023.2251662"},{"key":"e_1_2_15_166_1","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2022.2095270"},{"key":"e_1_2_15_167_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13051336"},{"key":"e_1_2_15_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2022.02.001"},{"key":"e_1_2_15_169_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15501"},{"key":"e_1_2_15_170_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023\u2010021\u201001783\u20108"},{"key":"e_1_2_15_171_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415\u2010024\u201012567\u2010y"},{"key":"e_1_2_15_172_1","doi-asserted-by":"publisher","DOI":"10.3390\/children8070604"},{"key":"e_1_2_15_173_1","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.15171"},{"key":"e_1_2_15_174_1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13010110"},{"key":"e_1_2_15_175_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415\u2010024\u201012442\u2010w"},{"key":"e_1_2_15_176_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0298609"},{"key":"e_1_2_15_177_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2024.2443796"},{"key":"e_1_2_15_178_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010022\u201001866\u20104"},{"key":"e_1_2_15_179_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010022\u201001867\u20103"},{"key":"e_1_2_15_180_1","doi-asserted-by":"publisher","DOI":"10.1136\/spcare\u20102024\u2010004984"},{"key":"e_1_2_15_181_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2024.07.457"},{"key":"e_1_2_15_182_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10897\u2010015\u20109859\u2010z"},{"key":"e_1_2_15_183_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24497"},{"issue":"8","key":"e_1_2_15_184_1","first-page":"1","article-title":"CADTH Reimbursement Recommendation: Risdiplam (Evrysdi)","volume":"1","author":"CADTH","year":"2021","journal-title":"Canadian Journal of Health Technologies"},{"key":"e_1_2_15_185_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415\u2010013\u20107154\u20101"}],"container-title":["Annals of Clinical and Translational Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acn3.70274","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/acn3.70274","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acn3.70274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T06:13:36Z","timestamp":1770617616000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/acn3.70274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":184,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1002\/acn3.70274"],"URL":"https:\/\/doi.org\/10.1002\/acn3.70274","archive":["Portico"],"relation":{},"ISSN":["2328-9503","2328-9503"],"issn-type":[{"value":"2328-9503","type":"print"},{"value":"2328-9503","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-10-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}